Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
The Journal of Pathology. Clinical Research|April 22, 2025
AXL and SRC in clear cell renal cell carcinoma: absence of mutations, rare alternative splicing events, but association of protein expression with poor prognosisMuriel D Brada, Tülay Karakulak, Peter Schraml, et al.
Plos One|August 19, 2016
Discretization of Gene Expression Data Unmasks Molecular Subgroups Recurring in Different Human Cancer TypesManfred Beleut, Robert Soeldner, Mark Egorov, et al.
Plos One|March 19, 2013
Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancerZsuzsanna Varga, Peter Sinn, Florian Fritzsche, et al.
Neoplasia (New York, N.Y.)|December 17, 2013
Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencingDorothee Pflueger, Andrea Sboner, Martina Storz, et al.
Human Pathology|September 25, 2007
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancerKirsten D Mertz, Francesca Demichelis, Robert Kim, et al.
Cancer Genomics & Proteomics|January 3, 2012
KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinomaThomas Wiedl, Stéphane Collaud, Sven Hillinger, et al.
International Journal of Cancer|September 24, 2004
Different types of microsatellite instability in ovarian carcinomaGad Singer, Thore Kallinowski, Arndt Hartmann, et al.
Cancers|May 5, 2021
Spatial Distribution of Private Gene Mutations in Clear Cell Renal Cell CarcinomaAriane L Moore, Aashil A Batavia, Jack Kuipers, et al.
Pageof 12